Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solesence (SLSN) Total Current Liabilities: 2010-2025

Historic Total Current Liabilities for Solesence (SLSN) over the last 14 years, with Sep 2025 value amounting to $17.9 million.

  • Solesence's Total Current Liabilities fell 23.29% to $17.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.9 million, marking a year-over-year decrease of 23.29%. This contributed to the annual value of $25.8 million for FY2024, which is 65.33% up from last year.
  • Per Solesence's latest filing, its Total Current Liabilities stood at $17.9 million for Q3 2025, which was down 20.73% from $22.5 million recorded in Q2 2025.
  • Solesence's 5-year Total Current Liabilities high stood at $32.9 million for Q1 2025, and its period low was $7.3 million during Q4 2021.
  • For the 3-year period, Solesence's Total Current Liabilities averaged around $19.8 million, with its median value being $17.9 million (2025).
  • In the last 5 years, Solesence's Total Current Liabilities declined by 28.96% in 2024 and then surged by 169.98% in 2025.
  • Over the past 5 years, Solesence's Total Current Liabilities (Quarterly) stood at $7.3 million in 2021, then skyrocketed by 88.49% to $13.8 million in 2022, then rose by 12.68% to $15.6 million in 2023, then soared by 65.33% to $25.8 million in 2024, then declined by 23.29% to $17.9 million in 2025.
  • Its Total Current Liabilities stands at $17.9 million for Q3 2025, versus $22.5 million for Q2 2025 and $32.9 million for Q1 2025.